Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
October 11 2023 - 4:50PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF
1934
For the month of October 2023
Commission File Number 001-40996
MDXHEALTH SA
(Translation of registrant’s name into English)
CAP Business Center
Zone Industrielle des Hauts-Sarts
4040 Herstal, Belgium
+32 4 257 70 21
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
MDXHEALTH SA
MDxHealth SA (the “Company”) hereby furnishes the documents
attached hereto as Exhibits 99.1 and 99.2 in connection with its Extraordinary General Shareholders’ Meeting to be held on Friday,
November 3, 2023 at 3:00 p.m., Belgian time, at the offices of the notary public Stijn Raes, at Kortrijksesteenweg 1147, 9051 Ghent, Belgium,
or at such other place as will be indicated at that place at that time.
The information
in the attached Exhibits 99.1 and 99.2 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section,
nor shall they be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or
the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MDXHEALTH SA |
|
|
|
Date: October 11, 2023 |
By: |
/s/ Michael McGarrity |
|
|
Name: |
Michael McGarrity |
|
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1
Exhibit 99.2
Notice of The Bank of New York Mellon, as Depositary,
of
Extraordinary Shareholders’ Meeting of
MDxHeath SA
to be held on November 3, 2023
Only those Holders of ADSs of record on October
4, 2023 (the “ADS Record Date”) and
October 20, 2023 (the “Share Record Date”)
are entitled to vote at the Meeting
A Holder of American Depositary Shares (“ADSs”)
may instruct The Bank of New York Mellon, as Depositary, to endeavor, in so far as practicable, to vote or cause to be voted in the manner
set forth in a timely submitted Voting Instruction Form and as further described in this Notice the amount of Shares or other Deposited
Securities represented by the ADSs of MDxHealth SA (the “Company”) held by such Holder as of the ADS Record Date and the Share
Record Date, at the Extraordinary General Shareholders’ Meeting of the Company, to be held at the offices of the notary public Stijn
Raes, at Kortrijksesteenweg 1147, 9051 Ghent, Belgium November 3, 2023 at 3:00 p.m., to discuss and vote on the agenda items set forth
in the Voting Instruction Form.
Subject to Belgian law, the Articles of Association
of the Company, the provisions of or governing the Shares and any other Deposited Securities, and the terms of the Deposit Agreement among
the Company, the Depositary, and the Owners and Holders of ADSs, Holders of ADSs as of the ADS Record Date will be entitled to instruct
the Depositary as to the exercise of voting rights pertaining to the Deposited Securities represented by their ADSs. However, in order
to comply with the requirements of Belgian law, the voting instructions of any such Holder will be disregarded if the Depositary is unable
to confirm such Holder’s continued ownership of ADSs as of the Share Record Date. The Depositary agrees not to vote, cause to
be voted or attempt to exercise the right to vote that attaches to any Shares or any other Deposited Securities, other than in accordance
with valid voting instructions given or deemed given in compliance with the Deposit Agreement.
Holders of ADSs holding their ADSs in a brokerage
or custodian account through The Depository Trust Company (“DTC Holders”) as of the ADS Record Date must continue to own their
ADSs as of the Share Record Date and must instruct their broker or custodian to give voting instructions to the Depositary and to confirm
ownership of the ADSs as of the Share Record Date to the Depositary. The Depositary will attempt to verify with applicable brokers or
custodians the continued ownership by DTC Holders of ADSs as of the Share Record Date. Failure to confirm continued ownership of ADSs
by DTC Holders as of the Share Record Date will invalidate voting instructions previously delivered to the Depositary.
Holders of ADSs registered in their name on the
books of the Depositary (a “Registered Holder”) as of the ADS Record Date must timely deliver voting instructions to the Depositary
and continue to be the Registered Holder of such ADSs registered on the books of the Depositary as of the Share Record Date. If a Registered
Holder transfers or cancels ADSs at any time before the Share Record Date, any voting instructions delivered to the Depositary will be
invalidated. The Depositary will verify the continued registration on its books of the ADSs as of the Share Record Date in the name
of the instructing Registered Holders and will recognize as valid only the voting instructions that were timely received from Registered
Holders as of the ADS Record Date who continue to be Registered Holders as of the Share Record Date.
All duly completed Voting Instructions Forms must be received by
the Depositary from Holders of ADSs at the latest by 12:00 p.m. NY Time October 26, 2023.
For more information and to view relevant proxy materials, please visit
the Extraordinary General Shareholders’ Meetings (November 3, 2023) section on: https://mdxhealth.com/shareholder-information/
The Bank of New York Mellon, as Depositary
MDXHealth (CE) (USOTC:MXDHF)
Historical Stock Chart
From Apr 2024 to May 2024
MDXHealth (CE) (USOTC:MXDHF)
Historical Stock Chart
From May 2023 to May 2024